跳至主要内容
临床试验/EUCTR2012-005713-39-NL
EUCTR2012-005713-39-NL进行中(未招募)不适用

Response to influenza vaccination in lymphoma patients treated with CHOP and rituximab (RITUXIVAC) - REVIVA

St. Antonius Hospital0 个研究点开始时间: 2014年7月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients with multiple myeloma who are treated with lenalidomide with/without steroids.
  • 2. Age > 18 years
  • 3. Signing informed consent.
  • Control group:
  • 1. Age, sex and co-morbity matched
  • 2. Age >18 years
  • 3. Signing informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • 1. Fever at time of vaccination
  • 2. Completion of Lenalidomide therapy prior to vaccination
  • 3. previous/known allergic reaction to any of the components of the influenzavaccin given
  • Control group:
  • 1. Use of immune supressive drugs
  • 2. Fever at time of vaccination
  • 3. Previous/known allergic reaction to any of the components of the influenzavaccin given

研究者

相似试验

Reponse to vaccination in patients with... | 临床试验